Loading...
Loading...
India's biotin imports from UNITED STATES MINOR OUTLY total $2.2K across 21 shipments from 1 foreign suppliers. BIOLEGEND INC. leads with $2.2K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include BIOGENE INDIA. This corridor reflects India's pharmaceutical import demand for biotin — a concentrated sourcing relationship with select suppliers from UNITED STATES MINOR OUTLY.

BIOLEGEND INC. is the leading Biotin supplier from UNITED STATES MINOR OUTLY to India, with import value of $2.2K across 21 shipments. The top 5 suppliers — BIOLEGEND INC. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BIOLEGEND INC. | $2.2K | 21 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BIOGENE INDIA | $2.2K | 21 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Biotin suppliers from UNITED STATES MINOR OUTLY to India include BIOLEGEND INC.. The leading supplier is BIOLEGEND INC. with import value of $2.2K USD across 21 shipments. India imported Biotin worth $2.2K USD from UNITED STATES MINOR OUTLY in total across 21 shipments.
India imported Biotin worth $2.2K USD from UNITED STATES MINOR OUTLY across 21 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Biotin sourced from UNITED STATES MINOR OUTLY include BIOGENE INDIA. The largest buyer is BIOGENE INDIA with $2.2K in imports across 21 shipments.
The total value of Biotin imports from UNITED STATES MINOR OUTLY to India is $2.2K USD, across 21 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
21 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists